BACKGROUND: Donor -specific HLA antibody (DSA) is present in many kidney transplant patients whose biopsies are classified as no rejection (NR). We explored whether in some NR kidneys DSA has subtle effects not currently being recognized. METHODS: We used microarrays to examine the relationship between standard-of-care DSA and rejection-related transcript increases in 1679 kidney transplant indication biopsies in the INTERCOMEX study (ClinicalTrials.gov NCT01299168), focusing on biopsies classified as NR by automatically assigned archetypal clustering. DSA testing results were available for 835 NR biopsies and were positive in 271 (32%). RESULTS: DSA positivity in NR biopsies was associated with mildly increased expression of antibody-mediated rejection (ABMR)-related transcripts, particularly IFNG-inducible and NK cell transcripts. We developed a machine learning DSA probability (DSAProb) classifier based on transcript expression in biopsies from DSA-positive versus DSA-negative patients, assigning scores using 10-fold cross-validation. This DSAProb classifier was very similar to a previously described "ABMR probability" classifier trained on histologic ABMR in transcript associations and prediction of molecular or histologic ABMR. Plotting the biopsies using Uniform Manifold Approximation and Projection revealed a gradient of increasing molecular ABMR-like transcript expression in NR biopsies, associated with increased DSA (P<2 × 10-16). In biopsies with no molecular or histologic rejection, increased DSAProb or ABMR probability scores were associated with increased risk of kidney failure over 3 years. CONCLUSIONS: Many biopsies currently considered to have no molecular or histologic rejection have mild increases in expression of ABMR-related transcripts, associated with increasing frequency of DSA. Thus, mild molecular ABMR-related pathology is more common than previously realized.

Alberta Transplant Applied Genomics Centre Edmonton Alberta Canada

Department of Medicine Division of Nephrology and Transplant Immunology University of Alberta Edmonton Alberta Canada

Department of Nephrology and Transplant Center Institute for Clinical and Experimental Medicine Prague Czech Republic

Department of Nephrology Hannover Medical School Hannover Germany

Department of Pathology Medical University of Warsaw Warsaw Poland

Department of Surgery University of Wisconsin Madison Wisconsin

Departments of Surgery and Microbiology and Immunology University of Maryland Baltimore Maryland

Division of Nephrology and Dialysis Department of Medicine 3 Medical University of Vienna Vienna Austria

Division of Nephrology Virginia Commonwealth University Richmond Virginia

Pomeranian Medical University Department of Clinical Interventions and Department of Nephrology and Kidney Transplantation Samodzielny Publiczny Wojewodzki Szpital Zespolony Szczecin Poland

Zobrazit více v PubMed

Haas M, Loupy A, Lefaucheur C, Roufosse C, Glotz D, Seron D, et al. : The Banff 2017 Kidney Meeting Report: revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials. Am J Transplant 18: 293–307, 2018 PubMed PMC

Senev A, Coemans M, Lerut E, Van Sandt V, Daniëls L, Kuypers D, et al. : Histological picture of antibody-mediated rejection without donor-specific anti-HLA antibodies: clinical presentation and implications for outcome. Am J Transplant 19: 763–780, 2019 PubMed

Halloran PF, Reeve J, Akalin E, Aubert O, Bohmig GA, Brennan D, et al. : Real time central assessment of kidney transplant indication biopsies by microarrays: The INTERCOMEX Study. Am J Transplant 17: 2851–2862, 2017 PubMed

Reeve J, Böhmig GA, Eskandary F, Einecke G, Lefaucheur C, Loupy A, et al. ; MMDx-Kidney study group : Assessing rejection-related disease in kidney transplant biopsies based on archetypal analysis of molecular phenotypes. JCI Insight 2: e94197, 2017 PubMed PMC

Reed EF, Rao P, Zhang Z, Gebel H, Bray RA, Guleria I, et al. : Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA. Am J Transplant 13: 1859–1870, 2013 PubMed PMC

Callemeyn J, Ameye H, Lerut E, Senev A, Coemans M, Van Loon E, et al. : Revisiting the changes in the Banff classification for antibody-mediated rejection after kidney transplantation. Am J Transplant 21: 2413-2423, 2021 PubMed

Reeve J, Böhmig GA, Eskandary F, Einecke G, Gupta G, Madill-Thomsen K, et al. ; INTERCOMEX MMDx-Kidney Study Group : Generating automated kidney transplant biopsy reports combining molecular measurements with ensembles of machine learning classifiers. Am J Transplant 19: 2719–2731, 2019 PubMed

Halloran K, Parkes MD, Chang J, Famulski K, Reeve J, Hachem R, et al. : Molecular detection of rejection-like changes in proximal bronchial mucosal lung transplant biopsies: initial findings of the INTERLUNG study. J Heart Lung Transplant 37: S80–S81, 2018

Lê S, Josse J, Husson F: FactoMineR: AnRPackage for multivariate analysis. J Stat Softw 25: 18, 2008

Konopka T: umap: Uniform Manifold Approximation and Projection. R package version 0240, 2019. Available at: https://cran.r-project.org/package=umap. Accessed February 18, 2021

Kuhn M: caret: Classification and Regression Training. R package version 6.0-81 ed., 2018. Available at: https://CRAN.R-project.org/package=caret. Accessed February 18, 2021

Sellarés J, Reeve J, Loupy A, Mengel M, Sis B, Skene A, et al. : Molecular diagnosis of antibody-mediated rejection in human kidney transplants. Am J Transplant 13: 971–983, 2013 PubMed

Therneau T: A package for survival analysis in R. R package version 32-7, 2020. Available at: https://CRAN.R-project.org/package=survival. Accessed February 18, 2021

Kassambara A, Kosinski M, Biecek P: survminer: drawing survival curves using 'ggplot2'. R package version 048, 2020. Available at https://CRAN.R-project.org/package=survminer. Accessed February 18, 2021

Einecke G, Reeve J, Gupta G, Böhmig GA, Eskandary F, Bromberg JS, et al. ; INTERCOMEX Investigators : Factors associated with kidney graft survival in pure antibody-mediated rejection at the time of indication biopsy: Importance of parenchymal injury but not disease activity. Am J Transplant 21: 1391–1401, 2021 PubMed

Halloran PF, Venner JM, Madill-Thomsen KS, Einecke G, Parkes MD, Hidalgo LG, et al. : Review: The transcripts associated with organ allograft rejection. Am J Transplant 18: 785–795, 2018 PubMed

Konvalinka A, Tinckam K: Utility of HLA antibody testing in kidney transplantation. J Am Soc Nephrol 26: 1489–1502, 2015 PubMed PMC

Tait BD: Detection of HLA antibodies in organ transplant recipients—Triumphs and challenges of the solid phase bead assay. Front Immunol 7: 570, 2016 PubMed PMC

Koenig A, Mezaache S, Callemeyn J, Barba T, Mathias V, Sicard A, et al. : Missing self-induced activation of NK cells combines with non-complement-fixing donor-specific antibodies to accelerate kidney transplant loss in chronic antibody-mediated rejection. J Am Soc Nephrol 32: 479–494, 2021 PubMed PMC

Koenig A, Chen CC, Marçais A, Barba T, Mathias V, Sicard A, et al. : Missing self triggers NK cell-mediated chronic vascular rejection of solid organ transplants. Nat Commun 10: 5350, 2019 PubMed PMC

Diebolder CA, Beurskens FJ, de Jong RN, Koning RI, Strumane K, Lindorfer MA, et al. : Complement is activated by IgG hexamers assembled at the cell surface. Science 343: 1260–1263, 2014 PubMed PMC

Zhang Y, Boesen CC, Radaev S, Brooks AG, Fridman WH, Sautes-Fridman C, et al. : Crystal structure of the extracellular domain of a human FcγRIII. Immunity 13: 387–395, 2000 PubMed

Halloran PF, Venner JM, Famulski KS: Comprehensive analysis of transcript changes associated with allograft rejection: Combining universal and selective features. Am J Transplant 17: 1754–1769, 2017 PubMed

Halloran PF, Famulski K, Reeve J: The molecular phenotypes of rejection in kidney transplant biopsies. Curr Opin Organ Transplant 20: 359–367, 2015 PubMed

Hidalgo LG, Einecke G, Allanach K, Halloran PF: The transcriptome of human cytotoxic T cells: similarities and disparities among allostimulated CD4+ CTL, CD8+ CTL and NK cells. Am J Transplant 8: 627–636, 2008 PubMed

Parkes MD, Halloran PF, Hidalgo LG: Mechanistic sharing between NK cells in ABMR and effector T cells in TCMR. Am J Transplant 18: 63–73, 2018 PubMed

Halloran PF, Wadgymar A, Ritchie S, Falk J, Solez K, Srinivasa NS: The significance of the anti-class I antibody response. I. Clinical and pathologic features of anti-class I-mediated rejection. Transplantation 49: 85–91, 1990 PubMed

Feucht HE, Felber E, Gokel MJ, Hillebrand G, Nattermann U, Brockmeyer C, et al. : Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection. Clin Exp Immunol 86: 464–470, 1991 PubMed PMC

Sis B, Reeve J, Einecke G, Bunnag S, Hidalgo L, Mengel M, et al. : Endothelial stress accelerates graft loss in kidneys with transplant glomerulopathy despite lack of C4D staining. Am J Transplant 9: 349–349, 2009

Einecke G, Sis B, Reeve J, Mengel M, Campbell PM, Hidalgo LG, et al. : Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 9: 2520–2531, 2009 PubMed

Callemeyn J, Lerut E, de Loor H, Arijs I, Thaunat O, Koenig A, et al. : Transcriptional changes in kidney allografts with histology of antibody-mediated rejection without anti-HLA donor-specific antibodies. J Am Soc Nephrol 31: 2168–2183, 2020 PubMed PMC

Vaulet T, Divard G, Thaunat O, Lerut E, Senev A, Aubert O, et al. : Data-driven derivation and validation of novel phenotypes for acute kidney transplant rejection using semi-supervised clustering. J Am Soc Nephrol 32: 1084–1096, 2021 PubMed PMC

Transcriptomic Signatures of Antibody-mediated Rejection in Early Biopsies With Negative Histology in HLA-incompatible Kidney Transplantation

Targeting CD38 in Subclinical Antibody-mediated Rejection in HLA-incompatible Kidney Transplantation: A Case Report

Relating Molecular T Cell-mediated Rejection Activity in Kidney Transplant Biopsies to Time and to Histologic Tubulitis and Atrophy-fibrosis

Molecular diagnosis of ABMR with or without donor-specific antibody in kidney transplant biopsies: Differences in timing and intensity but similar mechanisms and outcomes

Zobrazit více v PubMed

ClinicalTrials.gov
NCT01299168